MediPal Holdings Future Growth
Future criteria checks 1/6
MediPal Holdings is forecast to grow earnings and revenue by 3.1% and 2% per annum respectively. EPS is expected to grow by 3.6% per annum. Return on equity is forecast to be 6% in 3 years.
Key information
3.1%
Earnings growth rate
3.6%
EPS growth rate
| Healthcare earnings growth | 20.9% |
| Revenue growth rate | 2.0% |
| Future return on equity | 6.0% |
| Analyst coverage | Good |
| Last updated | 05 Aug 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2027 | 3,772,052 | 38,329 | 40,339 | N/A | 4 |
| 3/31/2026 | 3,679,445 | 35,559 | 37,989 | N/A | 6 |
| 3/31/2025 | 3,619,877 | 34,899 | 67,000 | N/A | 6 |
| 6/30/2024 | 3,581,312 | 39,294 | N/A | N/A | N/A |
| 3/31/2024 | 3,558,732 | 41,474 | 42,448 | 61,843 | N/A |
| 12/31/2023 | 3,507,505 | 37,244 | N/A | N/A | N/A |
| 9/30/2023 | 3,453,601 | 38,636 | 40,543 | 56,888 | N/A |
| 6/30/2023 | 3,408,417 | 41,724 | N/A | N/A | N/A |
| 3/31/2023 | 3,360,008 | 38,806 | 2,642 | 16,146 | N/A |
| 12/31/2022 | 3,351,069 | 30,439 | N/A | N/A | N/A |
| 9/30/2022 | 3,333,073 | 28,222 | 11,523 | 26,954 | N/A |
| 6/30/2022 | 3,304,372 | 28,248 | N/A | N/A | N/A |
| 3/31/2022 | 3,290,921 | 29,423 | 42,339 | 61,216 | N/A |
| 12/31/2021 | 3,279,583 | 36,411 | N/A | N/A | N/A |
| 9/30/2021 | 3,265,951 | 30,523 | 25,259 | 45,124 | N/A |
| 6/30/2021 | 3,241,838 | 26,468 | N/A | N/A | N/A |
| 3/31/2021 | 3,211,125 | 23,926 | 18,780 | 34,448 | N/A |
| 12/31/2020 | 3,208,237 | 26,682 | N/A | N/A | N/A |
| 9/30/2020 | 3,186,651 | 33,329 | 58,488 | 84,718 | N/A |
| 6/30/2020 | 3,236,315 | 37,002 | N/A | N/A | N/A |
| 3/31/2020 | 3,253,079 | 37,968 | 29,565 | 56,917 | N/A |
| 12/31/2019 | 3,242,840 | 34,722 | N/A | N/A | N/A |
| 9/30/2019 | 3,253,495 | 35,443 | 15,495 | 33,428 | N/A |
| 6/30/2019 | 3,189,613 | 34,116 | N/A | N/A | N/A |
| 3/31/2019 | 3,181,928 | 34,359 | 45,225 | 63,716 | N/A |
| 12/31/2018 | 3,178,578 | 34,315 | N/A | N/A | N/A |
| 9/30/2018 | 3,169,344 | 34,122 | 55,224 | 75,079 | N/A |
| 6/30/2018 | 3,169,216 | 37,166 | N/A | N/A | N/A |
| 3/31/2018 | 3,146,314 | 34,780 | N/A | 63,558 | N/A |
| 12/31/2017 | 3,124,724 | 33,199 | N/A | N/A | N/A |
| 9/30/2017 | 3,093,743 | 31,086 | N/A | 45,376 | N/A |
| 6/30/2017 | 3,072,597 | 26,239 | N/A | N/A | N/A |
| 3/31/2017 | 3,063,900 | 29,011 | N/A | 47,954 | N/A |
| 12/31/2016 | 3,065,833 | 32,149 | N/A | N/A | N/A |
| 9/30/2016 | 3,072,868 | 32,201 | N/A | 53,535 | N/A |
| 6/30/2016 | 3,057,501 | 33,965 | N/A | N/A | N/A |
| 3/31/2016 | 3,028,187 | 30,771 | N/A | 21,985 | N/A |
| 12/31/2015 | 2,995,210 | 28,449 | N/A | N/A | N/A |
| 9/30/2015 | 2,953,707 | 26,052 | N/A | 25,185 | N/A |
| 6/30/2015 | 2,923,061 | 23,938 | N/A | N/A | N/A |
| 3/31/2015 | 2,872,905 | 23,687 | N/A | 80,466 | N/A |
| 12/31/2014 | 2,902,889 | 22,221 | N/A | N/A | N/A |
| 9/30/2014 | 2,909,858 | 21,592 | N/A | 55,806 | N/A |
| 6/30/2014 | 2,920,808 | 22,231 | N/A | N/A | N/A |
| 3/31/2014 | 2,947,798 | 25,485 | N/A | -72 | N/A |
| 12/31/2013 | 2,883,615 | 23,157 | N/A | N/A | N/A |
| 9/30/2013 | 2,860,467 | 19,380 | N/A | 9,233 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MEPD.F's forecast earnings growth (3.1% per year) is above the savings rate (2.5%).
Earnings vs Market: MEPD.F's earnings (3.1% per year) are forecast to grow slower than the US market (15% per year).
High Growth Earnings: MEPD.F's earnings are forecast to grow, but not significantly.
Revenue vs Market: MEPD.F's revenue (2% per year) is forecast to grow slower than the US market (8.7% per year).
High Growth Revenue: MEPD.F's revenue (2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MEPD.F's Return on Equity is forecast to be low in 3 years time (6%).